Yifan Pharmaceutical (002019.SZ) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct30

Yifan Pharmaceutical released FY2025 Q3 earnings on October 30 After-Market (BJT), actual revenue CNY 1.288 B, actual EPS CNY 0.0697

01:00

Yifan Pharmaceutical released FY2025 9 Months earnings on October 30 After-Market (BJT), actual revenue CNY 3.923 B, actual EPS CNY 0.3197

01:00

Oct23

Yifan Pharmaceutical FY2025 Q3 Earnings Release on October 31, 2025, After-Market (BJT)

02:16

Aug14

Efang Pharmaceutical Sees Significant Growth in Innovative Drug Sales and Advances Yilishu Commercialization

13:13

Yifan Pharmaceutical released FY2025 Semi-Annual Earnings on August 14 During-Market (BJT), actual revenue CNY 2.635 B, actual EPS CNY 0.25

01:00

Yifan Pharmaceutical released FY2025 Q2 earnings on August 14 During-Market (BJT), actual revenue CNY 1.308 B, actual EPS CNY 0.124

01:00

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 1.288 B, Net Income 84.14 M, EPS 0.0697

Aug15

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug14

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 1.308 B, Net Income 150.49 M, EPS 0.124

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More